patent.fyi
Applications  /  US 2026/0355078
United States Patent Application Publication

US 2026/0355078 A1

Published
Nov 12, 2026
Filed
Nov 13, 2023
Earliest date on the face
Nov 16, 2022
Classification
A61K 8/22
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.2Lower peroxide concentration

What ifWhat if the active component contains 6% (v/v) hydrogen peroxide before mixing?
Claim language“at a minimum 35% (v/v) hydrogen peroxide”

A fitted tray holds the mixed gel against the tooth surfaces. Hydrogen peroxide oxidizes stain compounds during repeated applications.

1.3Pyrophosphate peroxide stabilization

What ifWhat if sodium acid pyrophosphate serves as the peroxide stabilizer?
Claim language“sodium stannate”

Sodium acid pyrophosphate dissolves in the aqueous active component. Pyrophosphate binds trace metal ions that catalyze hydrogen peroxide decomposition during storage.

1.4Sulfuric acid ph adjustment

What ifWhat if sulfuric acid sets the pH of the active component?
Claim language“phosphoric acid”

Dilute sulfuric acid sets an acidic pH for peroxide storage. A buffered thickening component adjusts the pH when the two components mix.

1.5Metal removal before blending

What ifWhat if a fixed ion exchange bed removes trace metals from the dilution water and the formulation contains no EDTA?
Claim language“ethylenediaminetetraacetic acid”

Dilution water passes through a chelating resin bed that captures dissolved iron and copper. The treated water is blended with high-purity peroxide concentrate in polymer equipment to limit metal contamination.

1.6Capillary retention of liquid

What ifWhat if a porous insert in a fitted tray holds the liquid against the teeth without a thickening component?
Claim language“a thickening component”

A porous polyethylene insert lines the tooth-facing surface of the tray. Capillary forces retain the liquid in the insert, and peroxide diffuses through the wetted pores to the tooth surface.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Bench bleaching of stained enamel specimens

A dental materials laboratory uses the peroxide active component and aqueous acrylic thickener to treat stained enamel coupons held in a specimen rack. A removable mask defines an exposed window on each coupon, and a fixed-volume dispenser deposits freshly mixed gel into the window. A reflectance colorimeter measures each window before treatment and after the gel is rinsed away.

Component substitution

Hydroxyethyl cellulose replaces the acrylic resin

The thickening component contains hydroxyethyl cellulose dispersed and hydrated in water. A separate reservoir holds the hydrogen peroxide, sodium stannate, phosphoric acid, and EDTA solution. A metering head combines the two streams immediately before dispensing, and the hydrated cellulose gives the mixed gel its viscosity.

Parameter or scale variation

Metered batches for three specimen sizes

A bench dispenser holds the peroxide solution and acrylic thickener in separate reservoirs and uses two coupled positive displacement pumps to feed a static mixer. Three stroke settings deliver mixed volumes of 50, 100, or 200 microliters while maintaining the same component ratio. A rack holds three specimen sizes, and the operator selects the corresponding stroke setting before dispensing into a shallow well above each specimen.

Combination with existing systems

Gel delivery through a sectional tray

A thermoformed dental tray incorporates shallow wells over the facial surfaces of selected teeth. A dual chamber cartridge feeds the peroxide solution and aqueous acrylic thickener into a disposable static mixer. The mixer outlet fills each well before tray placement, and raised borders around the wells confine the gel to the selected surfaces.

Gel recovery through dental suction

The peroxide solution and aqueous acrylic thickener are mixed at the outlet of a dual chamber dispenser and deposited on the exposed tooth surface. A disposable suction tip positioned next to the treated surface connects to a chairside vacuum line through a collection canister. The tip lifts the bulk gel first, then collects rinse water and residual gel as the surface is irrigated.

Automated or data-driven variant

Gravimetric control of component dispensing

Two independently driven pumps feed the peroxide solution and aqueous acrylic thickener into a disposable mixing cup on a load cell. A controller tares the cup and meters each component sequentially until its programmed mass increment is reached. The controller checks both recorded increments against their tolerances before enabling a stirrer to blend the batch.

Specific version of a part

Separate peroxide syringe chamber

One chamber of a dual-barrel syringe holds the aqueous active component behind a separate piston. A common plunger drives both pistons and feeds the components into a static mixing tip.

Metered phosphoric acid addition

An aqueous phosphoric acid stock is metered into the active component under agitation. A peroxide-compatible pH probe measures the batch after mixing and indicates when it reaches the specified storage pH.

Crosslinked polyacrylic acid gel

Crosslinked polyacrylic acid powder disperses and hydrates in water. Partial neutralization converts carboxylic acid groups to carboxylate groups, causing the polymer network to swell and increase viscosity.

Deionized water for hydration

Water passes through mixed-bed ion exchange media to reduce dissolved ions. The treated water serves as the continuous phase in which the acrylic resin disperses and hydrates.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2019/0357523 A1
Published
Nov 28, 2019
Filed
Aug 2, 2019
Class
A01N 1/021
Document BUS 2022/0002226 A1
Published
Jan 6, 2022
Filed
Oct 3, 2019
Class
C07C 229/16
Claim 1
Document A
Document B
1.1an active component, which includes:
1.2at a minimum 35% (v/v) hydrogen peroxide;
1.3sodium stannate;
1.4phosphoric acid;
1.5ethylenediaminetetraacetic acid (EDTA); and
The preservative reagent comprises (i) polyethylene glycol (PEG), (ii) ethanol, (iii) paraformaldehyde (PFA), and (iv) ethylenediaminetetraacetic acid (EDTA).
A · US 2019/0357523 A1 · ¶ 7
An amorphous form of a chelating agent is provided, in particular wherein the chelating agent comprises ethylenediaminetetraacetic acid/edetic acid (EDTA), diethylenetriaminepentaacetic acid/pentetic acid (DTPA), nitrilotriacetic acid (NTA), amino tris(methylenephosphonic acid) (ATMP), ethylenediamine tetramethylene phosphonic acid (EDTMP), 1-hydroxyethane 1,1-diphosphonic acid (HEDP), ethylenediaminedisuccinic acid (EDDS), iminodisuccinic acid (IDS), hydroxamic acid, oxalic
B · US 2022/0002226 A1 · abstract
1.6a thickening component, comprising:
1.7an acrylic resin; and
1.8water.
The preservative reagent may be prepared by individually dissolving each of PEG, PFA and EDTA in deionized water, and then mixing selected amounts of the solutions with ethanol.
A · US 2019/0357523 A1 · ¶ 27

An empty cell means only that no passage was reproduced there.

Statements in these documents
As the results, there is a need for an effective preservative reagent that can stabilize tumor cells in urine specimen for the microfiltration.
A · US 2019/0357523 A1 · ¶ 4
Upon addition to a urine sample, cells in the sample, such as tumor cells, remain in an unaltered state for a period of time sufficient to allow analysis of the sample and cells therein when convenient for the researcher or laboratory performing the analysis.
A · US 2019/0357523 A1 · ¶ 6
Moreover, the amorphous particulates produced in accordance with the process of present invention present advantageous characteristics regarding particle size batch-to-batch consistency and solubility.
B · US 2022/0002226 A1 · ¶ 2
These agents can be applied, for example, in the pharmaceutical field particularly in novel formulations having these excipients in the composition.
B · US 2022/0002226 A1 · ¶ 2
Cite aspatent.fyi, US 2026/0355078 A1, claim 1, first published 2026-11-19T07:53:10-05:00, https://patent.fyi/US20260355078/, SHA-256 4897e2481ab2384611225fb99f5647922b46f86ae9beae83f85422ed27c3e00c
First published
Permanent addresshttps://patent.fyi/US20260355078/
Content fingerprint (SHA-256)4897e2481ab2384611225fb99f5647922b46f86ae9beae83f85422ed27c3e00c
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi